Celldex To Present At 2008 BIO Investor Forum

NEEDHAM, Mass.--(BUSINESS WIRE)--Celldex Therapeutics, Inc. (Nasdaq: CLDX) today announced that Anthony S. Marucci, President and Chief Executive Officer of Celldex Therapeutics, Inc., will present at the 7^th Annual Biotechnology Industry Organization (BIO) Investor Forum on Thursday, October 30^th, at 9:00 p.m., PT. The conference is being held October 29-31, 2008 in San Francisco at The Palace Hotel. A conference agenda is posted on the BIO web site at http://investorforum.bio.org.

About Celldex Therapeutics, Inc.

Celldex Therapeutics is an integrated biopharmaceutical company that applies its comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex’s immunotherapy platform includes a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators to create novel disease-specific drug candidates. For more information, please visit http://www.celldextherapeutics.com.